Category «Pharmaceuticals»

The Blind Alley of Financial Conflicts of Interest

“Follow the money,” Deep Throat warned Woodward and Bernstein as the two reporters were about to break open the Watergate scandal. Generally, this is good advice for anyone seeking to understand what is happening in a complicated business story. But not always. Former New England Journal of Medicine (NEJM) editor-in-chief Jerome Kassirer would have us …

Along with Risks, COX-2 Drugs Have Many Potential Benefits

In addition to your nuanced counsel on dealing with the crescendo of dire warnings about various drugs (“The Painkiller Panic”, Dec. 23), another factor that should be considered in the precipitous withdrawal of Vioxx and the untoward panic about various pain-relievers is the vast potential of the nonsteroidal anti-inflammatory agents (NSAIDs) in the chemoprevention of …

Price Controls Limit Drugs

Although it may be appropriate to criticize the revolving-door ethics involved when a former congressman becomes an advocate for an industry with which he had legislative dealings, the issue of government-controlled drug pricing is not a fair target (“Switch raises issues of loyalty,” Opinion, Jan. 3). This part of the Medicare drug bill is there …